Company / Tangible Book Value per Share
Axsome Therapeutics, Inc. Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$1.57
FY2025
5-year range
$0.42 / $4.11
FY2021-FY2025
Trend
+65.0%
vs FY2024
Sector context
#147 of 209
Health Care
What the data says
At $1.57, Axsome Therapeutics, Inc.'s tangible book value per share ranks #147 of 209 in the Health Care sector. Tangible Book Value per Share has fluctuated over the past 10 years, ranging from $0.03 in FY2018 to $5.25 in FY2019.
Based on SEC 10-K filings.
1.57 in FY2025 with a 5-year CAGR of -12.5%.
Declined from $4.11 to $1.57 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -15.8%
- 5-Year CAGR
- -12.5%
- 10-Year CAGR
- -
Sector benchmark
-98.3% below sector average
Key checks
Key Insights
- In FY2025, tangible book value per share increased 65.0% year-over-year.
- Ranks #147 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2019.
- Lowest tangible book value per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -1.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.57 | +65.0% |
| FY2024 | $0.95 | -76.9% |
| FY2023 | $4.11 | +56.7% |
| FY2022 | $2.62 | +531.6% |
| FY2021 | $0.42 | -86.4% |
| FY2020 | $3.06 | -41.8% |
| FY2019 | $5.25 | +14957.9% |
| FY2018 | $0.03 | -95.2% |
| FY2017 | $0.73 | -34.8% |
| FY2016 | $1.13 | -71.0% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026